Výsledky vyhledávání - Stephen E. Gitelman
- Zobrazuji výsledky 1 - 20 z 64
- Přejít na další stránku
-
1
-
2
-
3
-
4
Toward a molecular understanding of skeletal development Autor Adrian Erlebacher, Ellen Filvaroff, Stephen E. Gitelman, Rik Derynck
Vydáno 1995Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
Idiopathic Hypothalamic Diabetes Insipidus, Pituitary Stalk Thickening, and the Occult Intracranial Germinoma in Children and Adolescents* Autor Sudha L. Mootha, A. James Barkovich, Melvin M. Grumbach, Michael S. B. Edwards, Stephen E. Gitelman, Selna L. Kaplan, Felix A. Conte
Vydáno 1997Artigo -
12
A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Di... Autor Kevan C. Herold, Stephen E. Gitelman, Umesh Masharani, William Hagopian, Brygida Bisikirska, David Donaldson, Kristina I. Rother, Beverly Diamond, David M. Harlan, Jeffrey A. Bluestone
Vydáno 2005Artigo -
13
Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development? Autor Christine T. Ferrara, Susan Geyer, YF Liu, Carmella Evans‐Molina, Ingrid Libman, Rachel Besser, Dorothy Becker, Henry Rodriguez, Antoinette Moran, Stephen E. Gitelman, María J. Redondo
Vydáno 2017Artigo -
14
-
15
Functional Characterization of Vasopressin Type 2 Receptor Substitutions (R137H/C/L) Leading to Nephrogenic Diabetes Insipidus and Nephrogenic Syndrome of Inappropriate Antidiuresi... Autor Moulay Driss Rochdi, Gabriel Vargas, Éric Le Carpentier, Geneviève Oligny-Longpré, Stanford Chen, Abraham Kovoor, Stephen E. Gitelman, Stephen M. Rosenthal, Mark von Zastrow, Michel Bouvier
Vydáno 2010Artigo -
16
Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus Autor Kevan C. Herold, William Hagopian, Julie Auger, Ena Poumian-Ruiz, Lesley Taylor, David Donaldson, Stephen E. Gitelman, David M. Harlan, Danlin Xu, Robert A. Zivin, Jeffrey A. Bluestone
Vydáno 2002Artigo -
17
Immune Therapy and β-Cell Death in Type 1 Diabetes Autor Jasmin Lebastchi, Songyan Deng, Amir H. Lebastchi, Isabel Emma Eggleston Beshar, Stephen E. Gitelman, Steven M. Willi, Peter A. Gottlieb, Eitan M. Akirav, Jeffrey A. Bluestone, Kevan C. Herold
Vydáno 2013Artigo -
18
Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes Autor Holly K. O’Donnell, Kimber M. Simmons, Stephen E. Gitelman, Terry Dex, Robert Hill, Mattias Wieloch, Julia Zaccai, Jennifer D’Souza, France Ginchereau Sowell, James Turnbull, Korey K. Hood
Vydáno 2025Artigo -
19
Nephrogenic Syndrome of Inappropriate Antidiuresis Autor Brian J. Feldman, Stephen M. Rosenthal, Gabriel Vargas, Raymond G. Fenwick, Eric A. Huang, Mina Matsuda‐Abedini, Robert H. Lustig, Robert S. Mathias, Anthony A. Portale, Walter L. Miller, Stephen E. Gitelman
Vydáno 2005Artigo -
20
Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes Autor Laura M. Jacobsen, Brian N. Bundy, Madison N. Greco, Desmond Schatz, Mark A. Atkinson, Todd M. Brusko, Clayton E. Mathews, Kevan C. Herold, Stephen E. Gitelman, Jeffrey P. Krischer, Michael J. Haller
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Type 1 diabetes
Biology
Immunology
Alternative medicine
Pathology
Placebo
Insulin
Immune system
Genetics
Clinical trial
Gastroenterology
Randomized controlled trial
Antibody
Biochemistry
Disease
MEDLINE
C-peptide
Clinical endpoint
Intensive care medicine
Law
Political science
CD8
Gene
Lymphoma
Rituximab